cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation.
| Website | http://www.cellvie.bio |
| Employees | 10 (8 on RocketReach) |
| Founded | 2018 |
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Cellular Therapy, Regenerative Medicine, Cell Therapy, Bioenergetics, Cellular Energy, Cell Health, Cellular Repair, Advanced Cell Therapies, Energy Production |
| Competitors | Zymeworks Inc., Geno, Allogene Therapeutics, Regenative Labs, UNITY Biotechnology, Sierra Oncology, CBMG Holdings, Aurelia Bioscience Ltd, Argos Therapeutics, Inc. (NASDAQ: ARGS), Mitochon Systems +31 more (view full list) |
Looking for a particular cellvie employee's phone or email?
Alexander Schueller is the Founder and CEO of cellvie.
8 people are employed at cellvie.